OTCPicks.com

FEATURED COMPANY

NEXPLORE CORPORATION (OTC: NXPC)

Detailed Quote: http://www.otcpicks.com/quotes/NXPC.php

Company Profile: http://www.otcpicks.com/nexplore/nexplore.htm

NeXplore Technologies is developing a Web 2.0 search engine and an assortment of social networking portals and tools that will enable users to personalize their Web experience and tailor it to their unique needs, interests, and online pursuits. The Company’s social computing platform, MyCircle.com, offers an enhanced, user-friendly graphical interface search engine, combined with innovative backend technology, which enables users to improve the way they connect with information and other people on the Worldwide Web. MyCircle’s Web 2.0 interface provides users with an online tool for sharing their Blogs, Voice-Over IP, photos and documents, podcasts and videocasts, classified advertising, instant messages, SMS text messages, Chat and personal profiles.

NXPC News:

June 5 - NeXplore Corporation Transitions Newly Acquired ClickCaster.com to NeXplore Grid Server

NeXplore Leverages Grid Layer From Layered Technologies for Fast Integration, Speedy Launch, Instant Scalability

NeXplore Corporation (OTC: NXPC) announced the successful transitioning of the recently acquired ClickCaster.com website to the NeXplore Grid Server. Powered by The Grid Layer hosting solution from Layered Technologies, in combination with 3Tera Inc.'s virtualization software AppLogic, the NeXplore Grid Server is the company's virtual private data center for efficiently and cost-effectively operating and managing NeXplore's growing portfolio of Web 2.0 products and destinations.

The rapid transitioning to the NeXplore Grid Server of ClickCaster.com enables NeXplore to quickly monetize and scale this popular website that provides tools for fast-and-easy audio and video podcast creation, publishing and management. Upon acquisition by NeXplore, ClickCaster.com had approximately 245,000 unique users, a number NeXplore plans to significantly grow by the end of 2008.

NeXplore currently utilizes the NeXplore Grid Server to host and manage NeXplore Search, the company's recently launched Web 2.0 search engine optimized for a superior end-user experience, rich-media display and social network integration. NeXplore is working to integrate ClickCaster.com podcasting capability into NeXplore Search.

"The quickness, low cost and relative ease with which we were able to transition ClickCaster.com to the NeXplore Grid Server validates our decision to utilize this cutting edge hosting and application management system," said Dion Hinchcliffe, chief technology officer for NeXplore Corporation. "The pace of innovation today is blistering. Web companies hobbled by the cost and complexity associated with traditional infrastructure — datacenter co-location, private racks and managed hosting services, etc. — are destined for extinction. The road to success in today's dynamic Web 2.0 world — the path that NeXplore is forging — is paved with glitch-free performance, speed-to-market and instant, on-demand scalability."

FEATURED COMPANY

KCM HOLDINGS CORPORATION (OTC: KCMH)

Detailed Quote: http://www.otcpicks.com/quotes/KCMH.php

Company Profile:
http://www.otcpicks.com/kcm-holdings/kcm-holdings-2.htm

KCM Holdings Corporation is a strategic business development and holdings company specializing in a broad range of business incubation, support, design and development ventures. For more information, visit www.thekcmgroup.com.

KCMH News:

June 5 - KCMH Enters Into a Purchase Agreement for an Established Sports Award & Memorabilia Company

KCM Holdings Corp. (OTC: KCMH) has entered into a purchase agreement for the acquisition of a successful 40-year longstanding sports award and memorabilia company with current annual revenues of $500,000. The acquisition is expected to be the first target of many as part of KCM’s distressed acquisition and incubation strategy. KCM immediately plans to implement in-house proprietary business development strategies that will include an e-commerce and branding program. The company will immediately compliment KCM’s other profitable in-house incubated ventures.

“This company is a prime example of KCM’s commitment to deliver value for our shareholders,” says KCM Director of Strategic Development, Chad Lefevre. “KCM’s strategy is to acquire, service, incubate or take public Micro- Cap companies that are successful, but may be stagnating, or require restructuring due to financial mismanagement, to get healthy and profitable again. In this case, the company is a profitable successful company with a 40-year history that just needs a strategic boost to grow revenues. That is what our business model and supporting web strategy is designed to do.” The acquisition is projected to be complete before the end of second quarter of 2008.

Visit www.thekcmgroup.com for more information on KCMH, including corporate presentations and financial reports.

FEATURED COMPANY

MONOGRAM ENERGY INCORPORATED (OTC: MGRN)

Detailed Quote: http://www.otcpicks.com/quotes/MGRN.php

Company Profile:
http://www.otcpicks.com/monogram-energy/monogram-energy.htm

Monogram Energy, Inc. is an independent energy company engaged in the acquisition, development, and exploitation of oil and gas properties. The company specializes in acquiring oil & gas leases with proven reserves that have the potential for increased production.

MGRN News:

June 2 - Monogram Energy, Inc. Announces 50% Production Capability Increase in Corsicana, Texas

Monogram Energy, Inc. (OTC: MGRN), an independent energy company engaged in the acquisition, development, and exploitation of oil and gas properties, announced that the Company's six wells on the T.W. Martin lease are currently producing, and that the three additional wells in the workover process should be completed by the end of June.

The 9 total wells are then expected to produce 2 barrels per day each for a projected yield of 540 barrels per month. This workover progress represents a 50% increase from the May 13th release projections of 270 barrels per month based on production estimates on the initial 6 wells.

The T.W. Martin lease comprises 70 acres with 12 wells and is located in Navarro County, Texas, which produces around 600,000 barrels annually.

"We're very pleased with our progress so far. With a little luck we might even complete our current workovers ahead of schedule," stated Mr. Billy King, Chief Executive Officer of Monogram Energy, Inc.

Mr. King became interested in the production of oil & gas during his ten years of employment as an attorney for the Halliburton Company, and with his representation of independent oil companies during his years as a private practitioner. Monogram Energy's goal is to maintain a high risk/reward profile, thereby enabling them to return the most value to its shareholders.

FEATURED COMPANY

COPPER KING MINING (OTC: CPRK)
"Up 12.28% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/CPRK.php

Company Profile:
http://www.otcpicks.com/copper-king-mining/copper-king-mining.htm

Copper King Mining Corporation currently owns approximately 1200 acres in the Drum Mountains of Utah, which are patent deeded mining claims which contain gold, silver and copper. The company recently added to its holdings by filing six more claims on land which was inside their holdings, but not patent deeded. Contiguous to that acreage is approximately 1100 acres of claims filed by Western Utah Copper Company. As the companies explored the concept of a joint venture on the Drum Mountain properties, it was decided that a very viable consideration was to join the total assets of both companies.

CPRK News:

June 3 - Copper King Mining Corporation Announces Commitment for Long-Term Financing

OCS Capital Group, LLC Delivers Permanent Financing Commitment Letter

Copper King Mining Corporation (OTC: CPRK), an ore mining, processing, and exploration company located in Milford, Southern Utah, announced that it has obtained a long-term financing commitment for the company’s copper mining and milling operations from OCS Capital Group LLC (OCS).

The OCS financing commitment represents a firm $100,000,000 project funding commitment. The funding is drawn against federal revenue bonds. The bonds, when issued, will be purchased by OCS’s investment banking house. The parties expect it to take up to 4 months to complete the entire funding. OCS is currently negotiating to assist in providing a bridge loan for the company for ongoing operational needs.

OCS, an OCS American Limited Liability Company, is an international bond-law consulting firm with offices in Pennsylvania, Washington DC, and Albuquerque, NM. It is also a consultant on government relations and government affairs. It provides technical and professional services to local, municipal, state and federal government agencies in the United States and South America.

OCS past projects have ranged from $25 Million, up to $8.3 Billion and vary from mining to commercial developments in cities and towns. Additional information will be released as approved by the lender.

FEATURED COMPANY

GENERAL AUTOMOTIVE COMPANY (OTCBB: GNAU)

Detailed Quote: http://www.otcpicks.com/quotes/GNAU.php

Company Profile:
http://www.otcpicks.com/general-automotive/general-automotive-2.htm

General Automotive Company ("GAC") is a provider of original equipment and aftermarket automotive parts, mobile electronics, and related automotive products at multiple levels of distribution throughout the United States and internationally. Through its two wholly owned subsidiaries, Global Parts Direct and OE Source, the company focuses its efforts on utilizing its relationships with manufacturers in China, Korea and Japan to bring state-of-the-art automotive parts, accessories and products to automobile manufacturers and major parts distributors in the U.S. For more information on GAC and its products, visit www.generalautomotive.com.

GNAU News:

June 3 - New Webcast Interview With General Automotive Company's President and CEO Now Available At TheGreenBaron.Com

General Automotive Company (OTCBB: GNAU) (“GA”), a provider of original equipment and aftermarket automotive parts, mobile electronics and related products, announces that a webcast interview with President and CEO Joseph DeFrancisci is now available for listening on the Webcasts page at www.thegreenbaron.com/Webcasts.htm.

This webcast is also available at www.StrictlyStocks.com, “Where Wall Street speaks to the World.”

ABOUT THE GREEN BARON REPORT

The Green Baron Report, a subsidiary of Evergreen Marketing, is an Internet stock market newsletter that focuses on low priced stocks that appear to have significant upside potential. For more information about Evergreen Marketing, Inc. and their subsidiary The Green Baron Investors Society, visit them on the web at www.EvergreenMarketingInc.com and www.TheGreenBaron.com or www.StrictlyStocks.com.

STOCKS TO WATCH

TERCICA INCORPORATED (NASD: TRCA)
"Up 99.09% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/TRCA.php

Tercica, Inc., a biopharmaceutical company, engages in the development and marketing of endocrine products. It markets Increlex, a replacement therapy for the treatment of short stature in children with severe primary insulin-like growth factor-1 deficiency, or severe primary IGFD, and for children with growth hormone gene deletion who have developed neutralizing antibodies to growth hormone. The company, pursuant to a strategic collaboration with Ipsen S.A., has the right to develop and commercialize Somatuline Depot for various indications other than opthalmic indications in the United States and Canada. Somatuline Depot is an injectable sustained-release formulation containing lanreotide, a somatostatin analogue. Tercica markets Increlex to pediatric endocrinologists in the United States. The company was founded in 2000 and is based in Brisbane, California.

TRCA News:

June 4 - Ipsen to Acquire Tercica

$9.00 per Share to Be Paid in Cash

Tercica, Inc. (NASD: TRCA) announced that Tercica and Ipsen, S.A. (Euronext: IPN) have entered into a definitive merger agreement by which an affiliate of Ipsen would acquire all of the shares of Tercica common stock that Ipsen does not currently own at a price of $9.00 per share in cash, which values Tercica at approximately $663 million. This transaction, which is subject to approval by Tercica stockholders holding a majority of the outstanding Tercica common stock, has been unanimously approved by Tercica’s Board of Directors following recommendation and approval by a Special Committee of Tercica’s Board of Directors comprised of three independent non-employee directors.

“The combination of Ipsen’s and Tercica’s development and product portfolios provides the opportunity to create a leading global endocrinology company,” said John A. Scarlett, M.D., Chief Executive Officer of Tercica. “We believe this transaction recognizes the value we have created at Tercica and provides our stockholders with attractive financial terms.”

Ipsen and its affiliates currently own approximately 25.3% of the outstanding Tercica common stock. Ipsen has agreed to exercise its outstanding Tercica warrant and convert its outstanding Tercica convertible notes promptly following today’s agreement. Upon such exercise and conversion, Ipsen and its affiliates will own approximately 42.7% of the outstanding Tercica common stock.

Certain stockholders of Tercica, who collectively own 1.4% of the outstanding Tercica common stock (after giving effect to the exercise and conversion of the warrants and convertible notes held by Ipsen and its affiliates), have executed voting agreements in conjunction with the merger pursuant to which they have agreed to vote the shares of Tercica common stock they hold in favor of the transaction. Ipsen and its affiliates have also agreed to vote their Tercica shares in favor of the merger.

Ipsen intends to finance this transaction through a combination of existing internal financial resources and bank loan financing.

The proposed cash offer represents a 104% premium to Tercica’s closing price on June 4, 2008 and a 74% premium to the volume-weighted average closing share price during the last three months.

Tercica’s Board of Directors, following the unanimous recommendation and approval by the Special Committee of Tercica’s Board of Directors who were advised by independent legal and financial advisors, have approved the merger agreement and recommend that Tercica’s stockholders vote to approve the merger.

The completion of the merger is subject to the satisfaction or waiver of customary closing conditions, including expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act.

Lehman Brothers is serving as financial advisor, and Morris, Nichols, Arsht & Tunnell LLP is serving as legal counsel, to the Special Committee of the Board of Directors of Tercica, and Tercica is represented by Cooley Godward Kronish LLP, Palo Alto, California.

ABOUT IPSEN

Ipsen is an innovation-driven international specialty pharmaceutical group with over 20 products on the market and a total worldwide staff of nearly 4,000. Its development strategy is based on a combination of specialty products, which are growth drivers, in targeted therapeutic areas (oncology, endocrinology and neuromuscular disorders), and primary care products which contribute significantly to its research financing. The location of its four Research & Development centers (Paris, Boston, Barcelona, London) and its peptide and protein engineering platform give the Group a competitive edge in gaining access to leading university research teams and highly qualified personnel. More than 700 people in R&D are dedicated to the discovery and development of innovative drugs for patient care. This strategy is also supported by an active policy of partnerships. In 2007, Research and Development expenditure was about €185 million, in excess of 20% of consolidated sales, which amounted to €920.5 million while total revenues amounted to €993.8 million. Ipsen’s shares are traded on Segment A of Eurolist by Euronext(TM) (stock code: IPN, ISIN code: FR0010259150). Ipsen’s shares are eligible to the “Service de Règlement Différé” (“SRD”) and the Group is part of the SBF 120 index. For more information on Ipsen, visit www.ipsen.com.

RUDY NUTRITION INCORPORATED (OTC: RUNU)
"Up 90.48% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/RUNU.php

Founded by Notre Dame sports legend Daniel "Rudy" Ruettiger, Rudy Nutrition, Inc. is a manufacturer of health conscious "Rudy" branded products that offer great taste as well as healthy choices for parents, kids, athletes, and active people looking for something special. Rudy Nutrition is focused on creating, distributing and licensing "Rudy" branded products that offer healthier alternative choices backed by Rudy's inspirational message of hope — that "never give up" spirit immortalized in the movie "RUDY" — on every product. For more information, visit www.rudynutrition.com, www.rudybeverageinc.com or www.avcg.net.

RUNU News:

June 3 - Super Bowl XXII MVP Doug Williams Signs on as a Celebrity Endorser for Rudy Nutrition

Rudy Nutrition, Inc. (OTC: RUNU) announced that Super Bowl XXII MVP Doug Williams has joined the Rudy Beverage team as a celebrity endorser.

Known for his MVP performance in Super Bowl XXII as quarterback of the Washington Redskins, Doug Williams exemplifies the "Dream Big. Never Quit." philosophy of Rudy Beverage. Doug was the first African American quarterback to start, win and be named Most Valuable Player of a Super Bowl. He also served as the head football coach for Grambling State University, where he was named national "Coach of the Year."

Doug will be making personal appearances, and be featured in marketing and promotional materials, and advertising campaigns on behalf of Rudy Beverage.

"I am proud to be joining Rudy and others in getting the word out about Rudy Beverage," said Doug Williams. "In addition to standing behind a great product, I truly believe in the Rudy message of dreaming big and never quitting."

Daniel "Rudy" Ruettiger, Founder and Chairman of Rudy Nutrition commented: "We are thrilled to be teaming up with a hero like Doug Williams. I truly admire what he stands for. Doug will make a significant contribution in our strategy to get Rudy Beverage in the hands of consumers everywhere."

In the coming weeks, more nationally recognized and respected sports personalities who embody the Rudy message of "Dream Big. Never Quit." will be announced.

AMERICHIP INTERNATIONAL INCORPORATED (OTCBB: ACII)
"Up 14.29% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/ACII.php

AmeriChip International, Inc., together with its subsidiaries, engages in developing patented technology for use in manufacturing. It develops Laser Assisted Chip Control technology, which is applicable to metal component that requires precision finishing. The company's technology eliminates ribbon-like steel chips that tangle around moving tool parts, automation devices, and other components essential to the machine processing of low to medium grade carbon steels, and nonferrous metal parts. It serves automotive, oil production and refining, aerospace, heavy truck, off-road construction, defense contractors, and farm implements manufacturing markets. AmeriChip has strategic alliances with GSI Lumonics, Creative Automation, and Seco Carboloy. The company is based in Clinton Township, Michigan.

ACII News:

June 5 - AmeriChip International Applies LACC Technology to Production of Truck Axle Components, Providing Up to a 50 Percent Cost Savings

AmeriChip International Inc. (OTCBB: ACII) is applying LACC technology to the production of truck axle components for a North American-based automaker.

Cost Savings Up To 50%

“AmeriChip's patented, proprietary Laser Assisted Chip Control (LACC) technology — when applied to the production of truck axle components — provides a cost reduction of up to 50%,” said Kenneth W. Mann, Interim CEO.

Prototype

The first parts have passed quality inspection and have been shipped to OEM parts manufacturers in Michigan for immediate installation.

Implementation

The successful completion of the prototype production cycle could lead to a full-fledged production contract of 15,000 pairs of truck axle components per year for this new 2009 truck, with production beginning in the third quarter of the calendar year 2008.

AmeriChip is currently in advanced discussions and negotiations with a number of other blue chip clients for LACC technology implementation across a number products.

PANGLOBAL BRANDS INCORPORATED (OTCBB: PNGB)
"Up 25.00% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/PNGB.php

Panglobal Brands, Inc., a development stage company, engages in the design, manufacture, and distribution of clothing and accessories for women and men in the United States and Canada. The company offers denim jeans, t-shirts, dresses, shorts, skirts, and knit and woven tops, as well as clothing for girls and children. It sells its products through a network of wholesale accounts. The company was founded in 2006 and is based in Huntington Park, California.

PNGB News:

June 4 - Panglobal Brands Acquires Scrapbook Brand

Panglobal Brands Inc. (OTCBB: PNGB) announced that it has signed a binding Term Sheet to acquire the Scrapbook brand label from Femme Knits, Inc. as well as selective other assets, including customer lists and current sales orders. Femme Knits Inc. was started in 1998 by Kelly Kaneda and the Scrapbook label was established in 2002. The Scrapbook label is aimed at the young contemporary market and is known for its mix and match prints and comfortable knit fabrics. Scrapbook products can be found at better department stores and boutiques, and major customers include Nordstrom’s, Dillard’s, Macy’s, Anthropologie, Top Shop (in London, UK), Delia’s, Forever 21 and Hot Topic.

Femme Knits, Inc. has achieved sales of over $56 million cumulative in the past three years with sales of $22.0 million in 2007. Panglobal Brands, Inc. will be employing Kelly Kaneda to be the new president of the Scrapbook division of Panglobal Brands, Inc. as well as many of the key design and production staff associated with the brand.

“We are excited to have Kelly and his team joining us, and believe that Scrapbook has an excellent brand name and reputation in the young contemporary market. With the addition of Scrapbook, we now will have brand diversification which will provide us with huge opportunities to design and sell into multiple distribution channels. We will continue to look for excellent apparel brand opportunities like Scrapbook which add to our stable of brands and bring exceptional design talent to Panglobal Brands, Inc. as well as adding to our credibility in the eyes of our key major customers,” said Stephen Soller, Chief Executive Officer of Panglobal Brands, Inc.

HEARTLAND OIL & GAS CORPORATION (OTCBB: HTOG)
"Up 25.00% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/HTOG.php

Heartland Oil and Gas Corp. engages in exploration, development, production, and sale of coal bed methane in the Cherokee basin and Forest City basin of northeast Kansas. The company owns and operates oil and gas leases located on approximately 645,000 acres of property in the Forest City and Cherokee basins in eastern Kansas; 700 acres of property in Palo Pinto County, Texas; and 3,000 acres in Jack County, Texas. It also holds properties in Kansas in the south block, located on the Cherokee basin; and the north block, located in the Forest City basin. In addition, the company engages in the processing and sale of gas through pipelines from its Lancaster wells. As of December 31, 2007, Heartland Oil and Gas had proved developed net reserves of 2,410,484 thousand cubic feet of gas; and 3,002 thousand barrels of crude oil. The company was founded in 1998 and is based in Houston, Texas. Heartland Oil & Gas Corp. operates as a subsidiary of Universal Property Development and Acquisition Corporation.

HTOG News:

June 2 - Heartland Pursues Institutional/Private Equity Financing to Proceed with 300 Well Drilling Program

The management of Heartland Oil and Gas Corp. (OTCBB: HTOG) (FWB: HOCA) recently initiated contact with institutional investors/private equity funds that specialize in oil and gas exploration and production and pipeline construction. These discussions have focused on the development of at least 300 wells over the next 12 to 24 months.

In preparation for these discussions, Heartland previously developed gas-in-place-maps and identified 300 drilling locations in its Southeast Kansas area of operation. Heartland also obtained reports from its consulting petroleum engineers establishing reserve projections for the 10 year production life of each of these wells at 0.1BCF (100,000 MCF). At current natural gas prices of $12/MCF, this means that every well should produce $1.2 million over the life of the well.

Based on Heartland’s experience and knowledge obtained as a result of drilling and completing 21 wells, an injection well and building a 4 ½ mile pipeline, 99% of all wells drilled and completed in the Cherokee Basin produce gas in commercial quantities and the cost of each well on a turnkey basis including pipelines, flow lines and an injection well for every thirty producing wells is $130,000.

Heartland currently operates 38 wells in Miami County, Kansas, recently drilled and producing under this valuation formula. With the drilling of 300 additional wells at a total cost of $39 million, Heartland’s revenues should continue to grow at this rate or more in the ten years following completion of this expansion program.

“These numbers represent only the organic growth projected for our Kansas operations,” reports Heartland Spokesman Jack Baker. “Heartland also has significant properties in Texas that currently generate even more revenue. Based on these numbers and on the limited number of shares issued and outstanding on a fully diluted basis, we are very optimistic about the prospects for expanding shareholder value.”

PHARMACYCLICS INCORPORATED (NASD: PCYC)
"Up 20.00% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/PCYC.php

Pharmacyclics, Inc., a pharmaceutical company, is developing drugs to treat cancer and other diseases. Its pharmaceutical agents are synthetic small molecules designed to target key biochemical pathways in diseased cells. The company's product candidate, Xcytrin (motexafin gadolinium) Injection, an anti-cancer agent with a novel mechanism of action, has completed Phase III trials in oncology and is in Phase II trials for patients with non-small cell lung cancer. Its products also include PCI-24781, a histone deacetylase inhibitor in Phase I trial in patients with advanced relapsed solid tumors; PCI-24783, a preclinical stage small molecule inhibitor of Factor VIIa for cancer therapy; and PCI-32765, a preclinical stage small molecule tyrosine kinase inhibitor to treat B cell malignancies and autoimmune disease. Pharmacyclics has a license agreement with the University of Texas to develop and commercialize porphyrins, expanded porphyrins, and other porphyrin-like substances covered by its patents. The company was founded in 1991 and is headquartered in Sunnyvale, California.

PCYC News:

June 5 - Phase 1/2 Trial of Motexafin Gadolinium Plus Antibody Targeted Radiation Therapy Demonstrates High Complete Response Rate in Patients With Non-Hodgkin's Lymphoma

Pharmacyclics, Inc. (NASD: PCYC) announced final data from a Phase 1/2 study showing a 46 percent complete response rate in patients with multiply recurrent non-Hodgkin's lymphoma (NHL) who were treated with motexafin gadolinium (MGd, Xcytrin®) in combination with Yttrium-90 Ibritumomab Tiuxetan (Zevalin(TM)), an approved antibody-targeted radiation therapy. The data were presented during the 10th International Conference on Malignant Lymphoma being held this week in Lugano, Switzerland.

The Phase 1/2 study was conducted in 29 patients with advanced relapsed lymphomas, including 11 patients with aggressive lymphomas. Eighty-three percent of the patients were rituximab (Rituxan®) refractory. Patients were treated with a standard dose of Zevalin administered with 2.5 to 5.0 mg/kg of MGd given for six days. Of 28 evaluable patients, 46 percent showed a complete response and 11 percent showed a partial response for an overall response rate of 57 percent. Rituximab refractory patients showed an overall response rate of 86 percent, with a 64 percent complete response rate and a median time to progression of 14 months. Adverse events seen were related to bone marrow suppression, an expected side effect of treatment with Zevalin.

"Motexafin gadolinium has been shown to have single agent activity in lymphoma and is synergistic with radiation therapy. This study shows a high rate of durable complete responses, especially in rituximab refractory patients," said Andrew M. Evens, D.O., M.S., Department of Hematology/Oncology, Northwestern University Feinberg School of Medicine, and lead author of the study.

Pharmacyclics has been developing MGd for use in combination with radiation therapy for treatment of brain metastases from lung cancer. A previous phase 3 trial showed that the addition of MGd to whole brain radiation therapy (WBRT) improved the median time to neurologic progression from 10.0 months to 15.4 months (P=0.12). At the 2007 American Society of Clinical Oncology Annual Meeting (ASCO), Pharmacyclics announced final results from a Phase 2 clinical trial in patients with brain metastases indicating that MGd improved the efficacy of targeted stereotactic radiosurgery.

"These results in lymphoma are consistent with motexafin gadolinium's known synergy with radiation, especially with targeted radiation therapy given over a short time as is the case with Zevalin, and with stereotactic radiation," said Richard A. Miller, M.D., president and chief executive officer of Pharmacyclics, and a co-author on the lymphoma study.

Zevalin is a radiolabeled antibody approved for treatment of patients with relapsed non-Hodgkin's lymphoma. Zevalin binds to tumor cells and emits radiation to the tumor site. Previously reported studies in the literature have shown that Zevalin alone produces a 15% complete response rate with median time to tumor progression of about seven months in rituximab refractory patients.

ABOUT MOTEXAFIN GADOLINIUM (MGD, XCYTRIN)

Pharmacyclics is developing MGd as an anti-cancer agent with a novel mechanism of action that is designed to selectively concentrate in tumors and induce apoptosis (programmed cell death). Its multifunctional mode of action, including its magnetic resonance imaging (MRI) detectability, provides the opportunity for MGd to be used in a broad range of cancers. At the 2007 American Society of Clinical Oncology Annual Meeting (ASCO), Pharmacyclics announced final results from a Phase 2 clinical trial indicating that MGd may improve the efficacy of stereotactic radiosurgery by enhancing the activity of radiation and by providing more accurate MRI treatment planning and better defining the treatment field in patients with brain metastases from solid tumors. MGd allowed physicians to identify occult brain metastases in 24% of patients that were missed with standard MRI contrast agents and were amenable to stereotactic radiosurgery.

MGd's non-overlapping toxicity makes it an appealing agent to use in combination with standard chemotherapy regimens. In previously conducted randomized trials, MGd combined with WBRT has been shown to prolong time to neurologic progression in patients with brain metastases from non-small cell lung cancer (NSCLC). Pharmacyclics recently completed patient enrollment in three Phase 2 trials evaluating MGd in patients with advanced relapsed NSCLC. These multi-center trials will evaluate MGd as a single agent, in combination with Taxotere® (docetaxel), and in combination with Alimta® (pemetrexed).

ORAMED PHARMACEUTICALS INCORPORATED (OTCBB: ORMP)
"Up 11.84% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/ORMP.php

Oramed Pharmaceuticals is a technology pioneer in the field of oral delivery solutions for drugs and vaccines presently delivered via injection. Oramed is seeking to revolutionize the treatment of diabetes through its patented flagship product, an orally ingestible insulin capsule currently in phase 2 clinical trials. Established in 2006, Oramed's technology is based on over 25 years of research by top research scientists at Jerusalem's Hadassah Medical Center. The Company's corporate and R&D headquarters are based in Jerusalem. For more information, visit www.oramed.com.

ORMP News:

June 4 - Oramed Pharmaceuticals to Present Oral Insulin Trial Results at ADA Conference June 6-10 in San Francisco

Oramed Pharmaceuticals, Inc. (OTCBB: ORMP) (www.oramed.com), a developer of oral delivery systems, announced that it has been selected to display its abstract, entitled Pharmacokinetics (PK) and Pharmacodynamics (PD) of Oral Insulin in Healthy Subjects, at the upcoming 68th Annual American Diabetes Association's Scientific Sessions Conference in San Francisco, highlighting the successful results from its oral insulin trials on healthy volunteers.

The abstract will also be printed in the Scientific Sessions Abstract Book, the June 2008 supplement to the journal Diabetes.

Oramed's technology will be included in an oral presentation by Prof. Dr. Lutz Heinemann, CEO of Profil Institute for Metabolic Research, "Pharmacokinetics and Pharmacodynamics of Alternate Insulin Delivery Systems," on Saturday, June 7, 2008 from 4 pm to 6 pm.

"The selection of Oramed as one of the companies to exhibit at Scientific Sessions is a great opportunity that allows us to present our data from human trials to the leading scientists in the diabetes field from all over the world," said Nadav Kidron, Oramed CEO.

Oramed's abstract poster has been assigned presentation number 425-P Clinical Therapeutics/New Technology - Insulin Delivery Systems and is available for viewing throughout the conference. A representative of the company will be available to answer questions on Saturday, June 7 from 6-7PM and from 12-2PM on Monday, June 9 at San Francisco's Moscone Convention Center, Hall D.

For more information about the ADA and the upcoming conference, visit http://professional.diabetes.org.

PROXIM WIRELESS CORPORATION (NASD: PRXM)
"Up 11.43% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/PRXM.php

Proxim Wireless Corporation provides high-speed wireless communications equipment and services in the United States and internationally. It offers broadband wireless access point-to-multipoint (PMP) systems that enable service providers, businesses, and other enterprises to connect end-users to a central hub or connect multiple facilities within their private networks; Tsunami MP.11 products, which support PMP applications in unlicensed frequency bands; WiMAX products that support PMP applications in licensed frequency bands; Wi-Fi Mesh products, which allow the creation of self-configuring and self-healing wireless networks; and MeshMAX products, that support licensed WiMAX frequencies and unlicensed frequencies for backhaul. The company also provides ORiNOCO access point products that offer wired Ethernet networks for enterprises and municipal area networks; and ORiNOCO client card products, which deliver mobile convenience, installation, and a configuration utility. In addition, it offers point-to-point (PTP) Lynx products, which are primarily used by wireless cellular operators to connect their base stations to other base stations and to existing wire-line networks; PTP Tsunami products, which enable its customers to expand or establish private networks by bridging Internet traffic among multiple facilities; QuickBridge 60250 product, a PTP wireless hop-in-a-box that provides 200 megabits per second of capacity in the 60 gigahertz unlicensed spectrum; and GigaLink products that enable fiberless transmission of data, voice, and video communication. The company provides its wireless solutions for the mobile enterprise, security and surveillance, last mile access, voice and data backhaul, and municipal networks. Proxim Wireless Corporation was founded in 1982. It was formerly known as Terabeam, Inc. and changed its name to Proxim Wireless Corporation in 2007. The company is headquartered in San Jose, California.

PRXM News:

June 4 - TW-Airnet of Taiwan Chooses Proxim for Municipal Wireless Network in Kinmen Islands

Part of Taiwan Government's M-city Project to Deploy Municipal Wireless Network in Major Cities

Proxim Wireless Corporation (NASD: PRXM), a leader in core-to-client solutions for broadband wireless networks, announced that it has supplied broadband wireless equipment to TW-Airnet to provide Wi-Fi network coverage for visitors to and residents of Kinmen County, a group of islands 200km away from Taiwan.

Kinmen County is located in the Southwest of the Fujian province in China, but is under the control of the Taiwanese Government. It is comprised of Kinmen, Leiyu and other small islands. Its total area is around 153 km2 and has a population of over 80, 000. Kinmen is the largest island, and 95% of the county's population resides there. Direct travel between mainland China and Kinmen was opened in 2002, and since then there has been a significant increase in tourism to the island from the mainland. As part of the Taiwan Government's M-city project to deploy municipal wireless networks in major cities and growing areas, it was decided that Kinmen County should be able to offer Wi-Fi access to tourists and visitors.

Chu-I Enterprise Co. specified and deployed a total wireless solution for the Kinmen County network. Proxim Tsunami GX products were installed to provide the wireless backbone for Kinmen, as well as to provide a link between Kinmen and the smaller islands. Proxim Tsunami MP.11 products were deployed to connect all the villages together and ORiNOCO AP4000 MR-LRs are used to provide ubiquitous Wi-Fi voice and data access in each village.

"We evaluated the market and after an extensive trial chose Proxim Wireless over a number of other vendors due to the resilient and scalable nature of Proxim's equipment, as well as the price point of the solution. We worked closely with Proxim Wireless to optimize the network design and deployment, which has been a great success," explained Mr Jim Yu, General Manager, Chu-I Enterprise Co., Ltd.

"We are really pleased with the Kinmen Wi-Fi network, which can be easily accessed by tourists and is very convenient for visitors to the islands. We look forward to working with Proxim Wireless and Chu-I Enterprise for the extension of the Kinmen network and further deployment of another M-city project," said Mr Liang Chen, Executive Vice President, TW-Airnet.

"Demand for municipal networks is exploding and we are having a lot of success across the globe with our municipal deployments. Adding capacity or extending networks into new areas requires scalability, flexibility and resilience. Our end-to-end wireless broadband product portfolio differentiates us from our competitors and allows us to be a 'one stop shop' for our customers like TW-Airnet who need a variety of wireless products to achieve their connectivity desires," added Joshua Chan, VP Asia Pacific Sales at Proxim Wireless

ABOUT TW-AIRNET AND CHU-I

TW-Airnet and Chu-I are both wholly owned subsidiaries of the Chung Hwa United Telecom (CHUT) group, the largest WISP in Taiwan. Founded in 2000, the CHUT group is a young and aggressive telecom company based in Taichung city in Taiwan. The CHUT group predicted the growing trend of using wireless technology in the telecom industry and decided to widely adopt the technology in its operation. CHUT now has the broadest wireless broadband coverage amongst its competitors in the country.